Kojepert 500mg Tablet SR
strip of 10.0 tablet.Prescription required
About this product:
| Salt Composition: | Tranexamic Acid (500mg) |
| Manufacturer: | Dermacia Healthcare |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Kojepert 500mg Tablet SR is used to treat bleeding and helps to prevent or reduce bleeding in various conditions. Kojepert 500mg Tablet SR is an anti-fibrinolytic medication that works by preventing the breakdown of blood clots, thereby controlling excessive bleeding during periods or after surgery. It is essential to take this medicine in the dose and duration as advised by the doctor. Common side effects include tiredness, nasal congestion, and pain in muscles, bones, or joints. It is generally safe for use in pregnant or breastfeeding mothers and patients with liver diseases. However, it is advised not to consume alcohol while taking this medicine due to the risk of excessive drowsiness.
Kojepert 500mg Tablet SR is an anti-fibrinolytic. It works by preventing the breakdown of blood clots to control excessive bleeding during periods or after surgery.
Can Kojepert 500mg Tablet SR cause pulmonary embolism?
Kojepert 500mg Tablet SR promotes blood clotting and can rarely cause blood clots to travel to the lungs (pulmonary embolism), which can be fatal. This side effect is not common in patients taking Kojepert 500mg Tablet SR, but it can occur in cases of overdosing, prolonged bedrest, or in individuals who are prone to blood clots. It is essential to discuss any concerns about this risk with your doctor, as they can help you weigh the benefits and risks of taking this medication.
Can you take Kojepert 500mg Tablet SR on an empty stomach?
Kojepert 500mg Tablet SR can be taken with or without food, accompanied by a glass of water. It is crucial to swallow the tablet whole and not crush or chew it.
Can I take Kojepert 500mg Tablet SR for more than 5 days?
The recommended dose and duration of Kojepert 500mg Tablet SR are determined by the underlying medical condition for which it is prescribed. For heavy menstrual bleeding, it is typically taken for up to 5 days. However, for other conditions, the duration may be shorter or longer, depending on the guidance of your prescribing physician.
Does Kojepert 500mg Tablet SR affect fertility?
No, Kojepert 500mg Tablet SR does not affect fertility. It is used to treat heavy menstrual bleeding and has been shown to have no impact on ovulation. Therefore, this medication is not a form of contraception and will not affect your chances of becoming pregnant.
Can Kojepert 500mg Tablet SR be taken for nose bleeding?
Yes, Kojepert 500mg Tablet SR can be used to treat nose bleeding. It helps to promote blood clotting and prevent further bleeding. If the bleeding persists, your doctor may recommend taking the medication for up to a week.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Kojepert 500mg Tablet SR is to be taken with food.
- Kojepert 500mg Tablet SR helps prevent or reduce heavy bleeding post-surgery and in conditions such as heavy periods, dysfunctional uterine bleeding, and nosebleeds.
- Your doctor will prescribe the lowest effective dose for the shortest possible time necessary to relieve your symptoms.
- If taking for heavy periods, take it on the first day as taking it before or after will not have any benefit.
- Your doctor may monitor your vision regularly while you are taking this medicine.
- Inform your doctor if you have a history of kidney or liver disease.
- Inform your doctor if there is no improvement in your bleeding after using this medicine for three consecutive periods.
Alcohol
Kojepert 500mg Tablet SR may cause excessive drowsiness with alcohol.
Breastfeed
Kojepert 500mg Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy
Kojepert 500mg Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
